CRP and COVID-19: After adjusting for potential confounding variables, found a nonlinear relationship between hs-CRP levels and 10-year CVD risk progression in T2DM patients infected with COVID-19 (P-overall<0.001, P-nonlinear=0.014) (Figure 2).